M1 Kliniken AG (ETR:M12)
18.88
+0.22 (1.18%)
Aug 4, 2026, 5:35 PM CET
M1 Kliniken AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 37.76 | 21.43 | 22.38 | 35.15 | 37.87 |
Cash & Short-Term Investments | 37.76 | 21.43 | 22.38 | 35.15 | 37.87 |
Cash Growth | 76.17% | -4.23% | -36.32% | -7.19% | 72.45% |
Accounts Receivable | 6.33 | 16.41 | 28.02 | 21.77 | 16.31 |
Inventory | 31.81 | 36.79 | 45.53 | 27.59 | 35.2 |
Other Current Assets | 13.43 | 8.92 | 14.66 | 22.8 | 20.82 |
Total Current Assets | 89.33 | 83.55 | 110.59 | 107.31 | 110.2 |
Net Property, Plant & Equipment | 9.41 | 12.91 | 13.79 | 17.18 | 15.27 |
Other Intangible Assets | 90.18 | 87.47 | 87.36 | 60.27 | 60.39 |
Other Long-Term Assets | 0.36 | 3.94 | 1.21 | 12.27 | 12.26 |
Total Assets | 189.29 | 187.87 | 212.95 | 197.02 | 198.11 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.44 | 12.97 | 33.26 | 19.22 | 12.84 |
Current Portion of Leases | 2.1 | 3.13 | 2.97 | 3.38 | 3.66 |
Unearned Revenue | 3.54 | 4.86 | 5.98 | 5.34 | - |
Other Current Liabilities | 17.6 | 22.79 | 16.04 | 9.53 | 26.92 |
Total Current Liabilities | 31.68 | 43.75 | 58.25 | 37.47 | 43.42 |
Long-Term Leases | 5.05 | 7.28 | 7.82 | 10.32 | 8.13 |
Other Long-Term Liabilities | 2.55 | 2.62 | 3.66 | 6.18 | 6.66 |
Total Long-Term Liabilities | 7.6 | 9.9 | 11.48 | 16.51 | 14.79 |
Total Liabilities | 39.28 | 53.66 | 69.73 | 53.97 | 58.21 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | 19.64 | 19.64 | 19.64 |
Treasury Stock | -20.81 | -20.81 | -6.37 | -13.95 | -11.81 |
Additional Paid-in Capital | 50.76 | 50.76 | 49.91 | 49.91 | 49.91 |
Accumulated Other Comprehensive Income | 0.43 | -0.76 | -0.04 | 0.02 | -0.12 |
Retained Earnings | 69.91 | 57.28 | 50.12 | 39.9 | 37.39 |
Total Common Shareholders' Equity | 100.28 | 86.46 | 113.25 | 95.52 | 95.03 |
Minority Interest | 30.09 | 28.12 | 29.97 | 47.53 | 44.88 |
Shareholders' Equity | 150.01 | 134.22 | 143.22 | 143.05 | 139.9 |
Total Liabilities & Equity | 189.29 | 187.87 | 212.95 | 197.02 | 198.11 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 7.15 | 10.42 | 10.79 | 13.7 | 11.78 |
Net Cash (Debt) | 30.62 | 11.02 | 11.59 | 21.45 | 26.08 |
Net Cash Growth | 177.91% | -4.92% | -45.97% | -17.79% | 160.99% |
Net Cash Per Share | 1.56 | 0.56 | 0.59 | 1.09 | 1.33 |
Book Value | 100.28 | 86.46 | 113.25 | 95.52 | 95.03 |
Book Value Per Share | 5.11 | 4.40 | 5.77 | 4.86 | 4.84 |
Tangible Book Value | 10.1 | -1.01 | 25.89 | 35.25 | 34.63 |
Tangible Book Value Per Share | 0.51 | -0.05 | 1.32 | 1.79 | 1.76 |